#Latest news with #ARCTWashington Post12-05-2025BusinessWashington PostArcturus Therapeutics: Q1 Earnings SnapshotSAN DIEGO — SAN DIEGO — Arcturus Therapeutics (ARCT) on Monday reported a loss of $14.1 million in its first quarter. On a per-share basis, the San Diego-based company said it had a loss of 52 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.58 per share.
Washington Post12-05-2025BusinessWashington PostArcturus Therapeutics: Q1 Earnings SnapshotSAN DIEGO — SAN DIEGO — Arcturus Therapeutics (ARCT) on Monday reported a loss of $14.1 million in its first quarter. On a per-share basis, the San Diego-based company said it had a loss of 52 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.58 per share.
12-05-2025
